| Code | CSB-MP5215MOW |
| Abbreviation | Recombinant Rhesus macaque IL6R protein, partial (Active) |
| MSDS | |
| Size | $138 |
| Order now | |
| Image |
|
| Have Questions? | Leave a Message or Start an on-line Chat |
IL-6 receptor alpha mediates the pleiotropic signaling of interleukin-6 in inflammation, immune regulation, and oncogenesis, making it a validated target for therapeutic intervention in cancer and autoimmune disease. This recombinant protein, spanning residues 20–365 and expressed in mammalian cells to preserve native glycosylation and folding, demonstrates robust binding to an anti-IL6R monoclonal antibody with a sub-nanomolar affinity constant of 0.381 nM as measured by surface plasmon resonance, confirming conformational integrity of the extracellular ligand-binding domain. Functional ELISA validation shows an EC50 of 26.59–31.72 ng/mL, providing quantitative benchmarks for competitive inhibition assays, therapeutic antibody epitope mapping, and blocking antibody screening workflows. With purity exceeding 95% by SDS-PAGE and endotoxin levels below 1.0 EU/μg, this protein meets the quality thresholds commonly required for SPR-based affinity characterization, biolayer interferometry studies, and small-molecule inhibitor screening in drug discovery programs targeting IL-6 signaling pathways.
There are currently no reviews for this product.